Radiotherapy Market is predicted to reach USD 12.5 billion at a CAGR of 5.03 % during the forecast period: 2025 to 2035

Technological Advancements and Rising Cancer Prevalence will Positively Impact the Global Radiotherapy Market at a CAGR of 8.85% during the Forecast Period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Radiotherapy Market” that contains information from 2025 to 2035. The Radiotherapy Market is estimated to register a CAGR of 8.85% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Radiotherapy Market — Varian Medical Systems (US), Elekta AB (SE), Accuray Incorporated (US), Siemens Healthineers (DE), Philips Healthcare (NL), GE Healthcare (US), Hitachi Ltd. (JP), CIVCO Medical Solutions (US), and Brainlab AG (DE).

Market Highlights

The Global Radiotherapy Market is accounted for to register a CAGR of 8.85% during the forecast period and is estimated to reach USD 22.96 Billion by 2035.

The market growth is driven by technological advancements, an increasing prevalence of cancer, and growing awareness regarding personalized treatment approaches. Innovations such as intensity-modulated radiation therapy (IMRT), stereotactic body radiotherapy (SBRT), and AI-integrated treatment planning systems are significantly enhancing precision, efficiency, and patient outcomes.

The demand for radiotherapy services is expanding due to the rising global cancer burden and aging populations. Healthcare facilities are investing in advanced equipment, digital treatment planning systems, and training to meet the growing patient load. Furthermore, favorable regulatory support and reimbursement policies are fostering the adoption of next-generation radiotherapy systems across developed and emerging economies.

Segment Analysis

The Global Radiotherapy Market has been segmented based on Technology, Application, End Use, and Treatment Type.

The Technology segment is bifurcated into External Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy, Intensity-Modulated Radiation Therapy, Stereotactic Radiosurgery. External Beam Radiotherapy (EBRT) dominates the market due to its versatility and proven efficacy, while Stereotactic Radiosurgery (SRS) is the fastest-growing segment, driven by the rising demand for precision-based, minimally invasive treatments.

The Application segment is bifurcated into Oncology, Palliative Care, Preoperative, Postoperative, Curative Treatment. Oncology holds the largest market share owing to the global rise in cancer cases, while Palliative Care is emerging rapidly with increasing focus on improving the quality of life for advanced-stage patients.

The End Use segment is bifurcated into Hospitals, Cancer Research Centers, Outpatient Facilities. Hospitals represent the dominant segment, supported by robust infrastructure and high patient inflow. Meanwhile, Cancer Research Centers are witnessing rapid growth due to rising investments in precision medicine and clinical trials.

The Treatment Type segment is bifurcated into Conventional Radiotherapy, Radiotherapy for Targeted Therapy, Combination Therapy. Conventional Radiotherapy remains the largest segment, whereas Combination Therapy is the fastest-growing, as integrated treatments with immunotherapy and targeted therapy gain prominence.

Region Analysis

By Region, the Radiotherapy Market is segmented into North America, Europe, Asia-Pacific, and Middle East & Africa. North America is the biggest market for radiotherapy, with about 45% of the world's share. This is because of the region's advanced healthcare system, high cancer rates, and large amounts of money spent on research and development. Agencies like the FDA have helped new technologies come to market, which has improved treatment options and patient outcomes. The market is growing even faster because more people want personalized medicine, especially precision therapies.

Key Findings of the Study

• The Global Radiotherapy Market is expected to reach USD 22.96 Billion by 2035, at a CAGR of 8.85% during the forecast period.


• North America accounted for the largest market share, while Asia-Pacific is the fastest-growing region.


• Based on Technology, External Beam Radiotherapy dominated the market in 2024.


• Based on Application, Oncology held the largest market share in 2024.


• Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens Healthineers, Philips Healthcare, GE Healthcare, Hitachi Ltd., CIVCO Medical Solutions, and Brainlab AG are the key market players.

Related Reports